InnoCare Pharma Ltd. (INNOCARE, 9969.HK) is listed on HKEX. The latest available quote update was captured at 2026-03-26 10:40:17.0.
Quote Snapshot
- Last Price: 12.400 HKD
- Day Change: +0.050 (+0.40%)
- Open: 12.410 HKD
- High: 12.970 HKD
- Low: 12.270 HKD
- Previous Close: 12.350 HKD
- Volume: 9.26 M
- Market Cap: 21.85 B
- P/E Ratio: N/A
- Dividend Yield: N/A
- Board Lot: 1,000
- ISIN: KYG4783B1032
- Industry: Healthcare - Pharmaceuticals & Biotechnology
Company Overview
InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company’s primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.
Risk & Return Metrics
Based on 490 trading days of close price data (daily returns, annualized using 252 trading days).
| Metric | Daily | Annualized |
|---|---|---|
| Expected Return | 0.2625% | 93.61% |
| Risk (Std Dev) | 3.6491% | 57.93% |
| Metric | Value |
|---|---|
| First Price (HKD) | 4.720 |
| Last Price (HKD) | 12.350 |
| Total Return | 161.65% |